Health Affairs, the leading journal of health policy research, offers a nonpartisan forum to promote analysis and discussions on improving health care and health policy. With our events, we bring ...

The time is now to align on a shared plan of action as a country to achieve diversity, equity, inclusion, and access in US ...

On September 30, a federal district judge in Florida held for the first time that lawsuits initiated by whistleblowers under the False Claims Act are unconstitutional, dismissing a Medicare fraud case ...

As our nation ages, with the need to address more mental health and loneliness challenges than ever, it is time to design new ...

Health Affairs' Editor-in-Chief Alan Weil interviews Janice Jhang of Harvard University about her recent paper that explores how regulatory and market forces are driving adoption of biosimilars.

Identification Of High-Veteran MA Plans For each year between 2016 and 2022, we defined high-veteran MA plans as MA plans with VHA enrollees exceeding 20 percent of their total enrollment, which ...

Before the COVID-19 pandemic, for-profit nursing homes’ revenue generally covered their costs, whereas not-for-profit nursing homes often needed donations and other nonpatient revenue to cover ...

Biosimilars present a key opportunity to contain the growing cost of biologic drug spending and to make essential medications more affordable. However, the lackluster performance of the US biosimilar ...

Health Insurance Gary Claxton and coauthors report the results of the twenty-sixth annual KFF Employer Health Benefits Survey, fielded in the first half of 2024. Among their many findings are that ...